Consortium for Food Allergy Research: Clinical Research Units (UM1) | Apply Online

Opportunity Summary:

This funding opportunity, titled "Consortium for Food Allergy Research: Clinical Research Units (UM1)" (RFA-AI-15-051), is a discretionary NIH cooperative agreement released by the U.S. Department of Health and Human Services, National Institutes of Health (HHS-NIH; specifically NIAID). It supports the Consortium for Food Allergy Research (CoFAR) by funding Clinical Research Units (CRUs) that will serve as the operational backbone for conducting the Consortium's clinical work. The FOA was posted on February 3, 2016, and had a closing date of June 30, 2016. It is associated with CFDA program numbers 93.855 and 93.856 under the broad activity category of Health.

The core purpose of the award is to establish and support CRUs that can implement CoFAR clinical trials and clinical studies. In practical terms, applicants are expected to have the infrastructure, personnel, and clinical research experience needed to run complex human-subjects research, including multi-site studies, under a coordinated Consortium structure. Beyond simply executing protocols developed elsewhere, the CRUs are also expected to help drive the science by proposing innovative, multi-center clinical trials focused on the prevention and treatment of food allergy. That emphasis signals an expectation for forward-looking trial concepts that can move the field, rather than routine or incremental clinical projects.

A defining feature of this opportunity is that it uses a cooperative agreement mechanism (UM1), which typically means NIH program staff will have substantial involvement in the funded activities compared with a standard research project grant. Under this model, the CRUs are not operating independently; they are meant to function as active partners in a larger coordinated network. To meet Consortium objectives, each CRU will work closely with the CoFAR Leadership Center, which is described as providing the scientific strategy and the organizational structure for CoFAR. In other words, the Leadership Center sets overarching direction and coordination, while the CRUs provide the on-the-ground clinical research capacity to enroll participants, execute trial procedures, collect and manage clinical data, and deliver studies consistently across multiple sites.

Eligibility is broad and includes many types of organizations that can credibly support clinical research. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories as stated); for-profit organizations other than small businesses; small businesses; and other entities as allowed under the FOA's additional eligibility guidance. This wide eligibility suggests the program is focused more on demonstrated capability to conduct high-quality clinical trials than on institutional type.

The opportunity does not specify an award ceiling or expected number of awards in the provided summary fields, so applicants would typically need to consult the full FOA text for budget expectations, project period, scope requirements, and details such as required clinical capabilities, data coordinating expectations, performance milestones, and collaboration requirements across the Consortium. Overall, the FOA is aimed at building a network of clinical sites that can collaboratively design and carry out multi-center trials that advance prevention and therapeutic strategies for food allergy, tightly integrated with a central Leadership Center that orchestrates scientific priorities and Consortium operations.

Browse more opportunities from the same agency: HHS-NIH11

Browse more opportunities from the same category: Health

Next opportunity: The National Syndromic Surveillance Program: Enhancing Syndromic Surveillance Capacity and Practice

Previous opportunity: Community Assistance Program - State Support Services Element (CAP-SSSE) - R2

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 15 051

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 15 051) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 15 051", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.